CPS Stress Urinary Incontinence (2018)

Member only benefit! AUA Guidelines provide a comprehensive and rigorous summary of evidence relating to a variety of disease conditions, providing an indispensable resource for urologic education. The Clinical Problem Solving (CPS) Protocols guideline-based Case Scenarios were designed to help maximize the impact of the guidelines. The purpose of this guideline is to provide a clinical framework for surgical treatment of female stress urinary incontinence.

Target Audience

  • Resident
  • Urologist

Learning Objectives

Upon completion of this course, participants will be able to:

  1. Interpret and explain the appropriate diagnosis, prevention and treatment of the related guideline.
  2. Perform appropriate methods of evaluation and management according to the guideline.
  3. Analyze the risks and benefits for treatment according to the guideline.
  4. Integrate AUA guidelines into clinical practice.
Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Non-Physician Participation
Course opens: 
01/10/2018
Course expires: 
01/10/2021
Rating: 
0

Authors:
Kathleen Kobashi, MD: Astellas: Meeting Participant or Lecturer; Allergan: Scientific Study or Trial; Medtronic: Consultant or Advisor, Meeting Participant or Lecturer; Medtronic: Scientific Study or Trial 
David Ginsberg, MD: Procept: Scientific Study or Trial 

Planner Disclosures
Education Council: 

Timothy Charles Brand, M.D. Nothing to disclose
Anthony A. Caldamone MD Nothing to disclose
Matthew S. Christman MD Nothing to disclose
John D. Denstedt MDCook UrologyOwner, Product Development
 Endourological SocietyLeadership Position
 Endourological SocietyHealth Publishing
 Interface BiologicsConsultant or Advisor
Jody Donaldson Nothing to disclose
Shelby Englert Nothing to disclose
Allen Gao MD, PhDPandomedxLeadership Position, Owner, Product Development
Matthew Thomas Gettman, M.D.COVR MedicalConsultant or Advisor
 Intuitive SurgicalConsultant or Advisor
 Exact SciencesScientific Study or Trial
Howard B. Goldman, MDallerganConsultant or Advisor
 MedtronicConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
 CookScientific Study or Trial
 NuvectraConsultant or Advisor
 AxonicsConsultant or Advisor
 NewUroConsultant or Advisor
William C. Huang, MDPhotocureScientific Study or Trial
 Karl StorzScientific Study or Trial
William C. Hulbert Jr. MD Nothing to disclose
Brant Inman, M.D., MS, FRCSCDendreonScientific Study or Trial
 Abbott LaboratoriesScientific Study or Trial
 Genentech IncScientific Study or Trial
 Combat MedicalConsultant or Advisor, Scientific Study or Trial
 FKD TherapiesScientific Study or Trial
 BioCancellConsultant or Advisor
 NucleixScientific Study or Trial
 UrogenScientific Study or Trial
Mark L. Jordan MD,FACS Nothing to disclose
Martin A. Koyle MD B
Yair Lotan ,MDabbottScientific Study or Trial
 CepheidConsultant or Advisor, Scientific Study or Trial
 Pacific EdgeScientific Study or Trial
 FKDScientific Study or Trial
 MDxHealthConsultant or Advisor, Scientific Study or Trial
 biocancellScientific Study or Trial
 Genomic HealthScientific Study or Trial
 GenomeDx Biosciences IncScientific Study or Trial
 photocureConsultant or Advisor, Scientific Study or Trial
Nicole Lara Miller ,MDBoston Scientific CorporationConsultant or Advisor, Meeting Participant or Lecturer
 Practical Reviews In UrologyHealth Publishing
Manoj Monga, MD, FACSFortecOther
Curtis Nickel, MDFarr LaboratoriesConsultant or Advisor
 TributeConsultant or Advisor
 AquinoxScientific Study or Trial
 GSKScientific Study or Trial
 PureTech HealthConsultant or Advisor
 AUAHealth Publishing
 NIHScientific Study or Trial
 Canadian Institute of Health ResearchScientific Study or Trial
 Interface BiologicsConsultant or Advisor
 Alvio TherapeuticsConsultant or Advisor
 Seikagaku CorporationConsultant or Advisor
Victor William Nitti MDAstellasHealth Publishing, Scientific Study or Trial
 AllerganHealth Publishing, Scientific Study or Trial
 Serenity PharmeuticalsInvestment Interest
 Cook MyositeScientific Study or Trial
 MedtronicScientific Study or Trial
Christopher Porter, MD Nothing to disclose
Ganesh V. Raj MD, PhDPtaresOwner, Product Development
 C-diagnostics corpConsultant or Advisor, Investment Interest
 amgenMeeting Participant or Lecturer
 Johnson and JohnsonConsultant or Advisor, Owner, Product Development
 AstellasMeeting Participant or Lecturer
 ASTELLASConsultant or Advisor, Meeting Participant or Lecturer
 JanssenOwner, Product Development
 BAYERConsultant or Advisor, Meeting Participant or Lecturer
 SANOFIConsultant or Advisor, Meeting Participant or Lecturer
 GaudiumRxLeadership Position, Investment Interest, Owner, Product Development
 MedivationConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
 EtiraRxLeadership Position, Investment Interest, Owner, Product Development
Jay D. Raman, MDAmerican Kidney Stone ManagementInvestment Interest
 Pacific Edge BiotechnologyConsultant or Advisor, Scientific Study or Trial
Lee Richstone, MD Nothing to disclose
Heather Schultz, NPSUNAMeeting Participant or Lecturer
 SUNALeadership Position
Karl-Dietrich SievertAMSMeeting Participant or Lecturer
 MedtronicsMeeting Participant or Lecturer, Scientific Study or Trial
 AllergenConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
 NeotractMeeting Participant or Lecturer
 StimguardMeeting Participant or Lecturer, Scientific Study or Trial
Joseph A. Smith Jr.,MD Nothing to disclose
Ryan Patrick Terlecki, MD, FACSAmerican Medical SystemsConsultant or Advisor, Other
 AllerganScientific Study or Trial
Edouard John Trabulsi, MD, FACSGenomeDxConsultant or Advisor

Accreditation Statement

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The American Urological Association designates this enduring material for a maximum of 2.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Learners

The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

Evidence Based Content

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA Disclosure Policy

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Resolution of Identified Conflict of Interest

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

Off-label or Unapproved Use of Drugs or Devices

The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer

The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

Reproduction Permission

Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

AUA Privacy and Confidentiality Policy

AUA Privacy and Confidentiality Policy can be found at: www.auanet.org/education/confidentiality-statement.cfm

Contact Information

American Urological Association
Office of Education
1000 Corporate Blvd.
Linthicum, MD 21090

Toll Free (U.S. only): 1-866-RING AUA (1-866-746-4282)
Phone: 410-689-3700
Fax: 410-689-3800

CME Information

For all inquiries regarding CME credit email: cme@AUAnet.org

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Non-Physician Participation

Accreditation Period

Course opens: 
01/10/2018
Course expires: 
01/10/2021
Please login or register to take this course.